Qure.ai

AI has never had more attention. But the real transformation begins when it moves from promise to practice. In this episode of Early Signs Podcast, Prashant Warier, Co-founder & CEO of Qure.ai, sits down with Dr. Amit Kakar, Managing Partner, Head of Novo Holdings Asia, for a wide-ranging conversation on what it will take for AI to create meaningful impact in healthcare. Despite the extraordinary attention around AI, Amit believes its adoption across healthcare is still only at the “tip of the iceberg.” The opportunity now is to move beyond the hype and embed AI into the systems, workflows and decisions where it can make a real difference. From radiologists working alongside AI to technology becoming almost invisible in clinical workflows, they explore what adoption could actually look like. They also get into how investors are thinking about AI companies, why Amit wouldn’t invest in a “pure AI” company, and where AI can create real value. The conversation looks further ahead to digital twins that could put a person’s entire health history at their fingertips, faster drug discovery and clinical trials, and just how far AI could ultimately take human health. In this episode, they discuss : • Why AI adoption still lags behind the hype • What happens to radiologists in an AI-enabled world • Why the best healthcare AI could become almost invisible • Why Amit wouldn’t invest in a “pure AI” company • What healthcare investors are looking for in the AI era • How digital twins could transform patient care • How AI could accelerate drug discovery and clinical trials • What healthcare could look like by 2050 Subscribe & watch the full conversation now! This episode will is now streaming on Spotify, Apple Podcasts, and all major platforms, click the links below: Spotify: https://bit.ly/3Vez0lA Apple Podcasts: https://bit.ly/3UJC6ht #EarlySignsPodcast #AIinHealthcare #HealthcareAI #DigitalHealth #QureAI Chapters: 00:00 - Opening Snippets 00:44 - Dr. Amit Kakar’s Journey 3:30 - The Evolution of Imaging Technology & Diagnostics 9:56 - The Future of Radiology 15:56 - The Challenges to AI Adoption 18:21 - Two Ways to Improve AI Adoption 22:09 - Investing in Healthcare Institutions that Use AI 26:10 - AI Will Not Take Your Job 30:48 - Investing in the Age of AI 34:32 - Why Pure Healthcare Will Always Need Humans 41:18 - AI’s Application Beyond Healthcare 46:39 - How AI Benefits Patients 51:38 - Healthcare in 2050 56:19 - The Role of Quantum in the Future 58:55 - Accessibility, Affordability, & Accelerating Drug Discovery

Healthcare has spent decades getting better at treating disease, could AI help us get better at detecting it early? In this episode of Early Signs, Dr. Sunil Verma, SVP & Global Head of Oncology at AstraZeneca, joins Prashant Warier to explore how AI could reshape healthcare — from giving patients a stronger voice in their care to moving beyond episodic “sick care” towards proactive, continuous care. AI is evolving fast. The opportunity is real. The next three years are the litmus test that determines how much of that potential translates into patient impact. So, what happens next? Watch the full conversation on Early Signs to find out. Full episode: https://youtu.be/NHphsZiJvN4?si=epcDMyy4W3HitdP- Also available on Spotify, Apple Podcasts and other major audio streaming platforms. Tap here to listen to the podcast: Spotify- https://lnkd.in/dFgtC3tV Apple- https://lnkd.in/dsc-YUCx #EarlySigns #EarlySignsPodcast #Qureai #AstraZeneca #DrSunilVerma #PrashantWarier #Leadership #ArtificialIntelligence #InnovationInHealthcare #ClinicalLeadership #HealthcareInnovation #FutureOfHealthcare